Clinical Trials Browser

Phase 4 × Carcinoma, Hepatocellular × Introns × Clear all

NCT00375661 2015-09-02

Low-dose Peg-interferon Plus Ribavirin (IFN/RBV) for Prevention of Hepatocellular Carcinoma (HCC) Recurrence in Patients Who Had Surgery to Remove Primary HCC

Phase 4 Completed

Gastrointestinal

Carcinoma, Hepatocellular, Hepatitis C, Chronic